analyst
CV
NASDAQ · CVRX
CVRx, Inc.
Healthcare · Medical - Devices
$1.75
Down-$0.09 (-5.14%)
Updated Oct 1, 2026, 6:50 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 220.41M
- P/E ratio
- -4.2
- Dividend yield
- 0.00%
- 52-week range
- $1.65 – $11.30
- Volume
- 4.27M
- Avg. volume
- 216.61K
Price performance · CVRX
CVRX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 30, 2026
CVRX closed at $1.75 after 20 trading sessions, down 43.00% for the selected period.
- Last close
- $1.75
- Period change
- -43.00%
- Period low
- $1.75
- Period high
- $3.07
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 30, 2026 | $2.63 | $2.65 | $1.65 | $1.75 | 4.27M |
| Sep 29, 2026 | $2.60 | $2.755 | $2.53 | $2.63 | 373.4K |
| Sep 28, 2026 | $2.69 | $2.79 | $2.53 | $2.59 | 381.98K |
| Sep 25, 2026 | $2.56 | $2.70 | $2.51 | $2.70 | 462.36K |
| Sep 24, 2026 | $2.73 | $2.73 | $2.51 | $2.53 | 693.69K |
| Sep 23, 2026 | $2.89 | $2.89 | $2.70 | $2.72 | 482.04K |
| Sep 22, 2026 | $2.95 | $3.07 | $2.86 | $2.89 | 666.18K |
| Sep 21, 2026 | $3.03 | $3.06 | $2.91 | $2.97 | 289.63K |
| Sep 18, 2026 | $2.99 | $3.065 | $2.92 | $3.04 | 810.57K |
| Sep 17, 2026 | $3.04 | $3.10 | $2.975 | $3.00 | 301.15K |
| Sep 16, 2026 | $2.99 | $3.13 | $2.92 | $3.02 | 415.89K |
| Sep 15, 2026 | $2.99 | $3.08 | $2.85 | $3.00 | 494.94K |
| Sep 14, 2026 | $2.86 | $3.00 | $2.79 | $3.00 | 548.39K |
| Sep 11, 2026 | $2.86 | $2.901 | $2.75 | $2.88 | 1M |
| Sep 10, 2026 | $2.83 | $2.86 | $2.70 | $2.86 | 373.41K |
| Sep 9, 2026 | $2.90 | $2.95 | $2.76 | $2.83 | 555.24K |
| Sep 8, 2026 | $3.03 | $3.05 | $2.81 | $2.93 | 619.56K |
| Sep 4, 2026 | $2.99 | $3.11 | $2.96 | $3.05 | 856.03K |
| Sep 3, 2026 | $3.11 | $3.175 | $2.98 | $3.01 | 614.54K |
| Sep 2, 2026 | $3.06 | $3.16 | $2.962 | $3.07 | 530.03K |
Latest CVRX news
The latest Smart Investors Daily articles mentioning CVRX.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…